½ÃÀ庸°í¼­
»óǰÄÚµå
1760890

¼¼°èÀÇ ½Å°æÀçȰ ±â±â ½ÃÀå

Neurorehabilitation Devices

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 504 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½Å°æÀçȰ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 45¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 18¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½Å°æÀçȰ ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 16.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 45¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½Å°æ ·Îº¿ ½Ã½ºÅÛÀº CAGR 18.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 20¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 12.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 5,280¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR21.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Å°æÀçȰ ±â±â ½ÃÀåÀº 2024³â¿¡ 6¾ï 5,280¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 2,820¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 21.1%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, °¢°¢ ºÐ¼® ±â°£ Áß¿¡ 12.2%¿Í 16.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ½Å°æÀçȰ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½Å°æÀçȰ ±â±â´Â ½Å°æ Àå¾Ö³ª ºÎ»óÀ» ÀÔÀº »ç¶÷µéÀÇ È¸º¹°ú ÀçȰÀ» µ½±â À§ÇØ °í¾ÈµÈ Ư¼ö µµ±¸ÀÔ´Ï´Ù. ÀÌ ÀåºñµéÀº ³úÁ¹Áß, ô¼ö ¼Õ»ó, ¿Ü»ó¼º ³ú¼Õ»ó, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ°ú °°Àº ½Å°æ ÅðÇ༺ ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀÇ ¿îµ¿ ±â´É, ÀÎÁö ´É·Â, Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» °³¼±ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½Å°æÀçȰ ±â±â¿¡´Â ·Îº¿ ¿Ü°ñ°Ý, ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI), ½Å°æ Àڱرâ, °¡»óÇö½Ç(VR) ±â¹Ý ÀçȰ ½Ã½ºÅÛ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â¼úµéÀº Ç¥ÀûÈ­µÈ Ä¡·á¸¦ Á¦°øÇϰí, ¹Ýº¹ ÈÆ·ÃÀ» ¿ëÀÌÇÏ°Ô Çϸç, ÀçȰ °á°ú¸¦ Çâ»ó½Ã۱â À§ÇÑ ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù.

½Å°æ ÀçȰ ±â±âÀÇ °³¹ß ¹× µµÀÔÀº ½Å°æ°úÇÐ, ·Îº¿ °øÇÐ ¹× µðÁöÅÐ °Ç°­ ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ·Îº¿ ¿Ü°ñ°Ý°ú º¸Á¶±â±¸´Â ȯÀÚ°¡ ¹Ýº¹ÀûÀÎ ¿îµ¿À» ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ½Å°æ °¡¼Ò¼º°ú ¿îµ¿ ȸº¹À» ÃËÁøÇϰí, BCI´Â ³ú¿Í ¿ÜºÎ ±â±â °£ÀÇ ¼ÒÅëÀ» ÃËÁøÇÏ¿© ȯÀÚ°¡ ÀÚ½ÅÀÇ ¿òÁ÷ÀÓÀ» Á¦¾îÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. °æµÎ°³ ÀÚ±â ÀÚ±Ø(TMS) ¹× °æµÎ°³ Á÷·ù Àü·ù ÀÚ±Ø(tDCS)°ú °°Àº ½Å°æ ÀÚ±Ø ÀåÄ¡´Â ÀÎÁö ¹× ¿îµ¿ ±â´ÉÀ» °³¼±Çϱâ À§ÇØ ½Å°æ Ȱµ¿À» Á¶ÀýÇϸç, VR ±â¹Ý ½Ã½ºÅÛÀº ÀÎÁö ¹× ½Åü ¿îµ¿À» À§ÇÑ ¸ôÀÔÇü ȯ°æÀ» Á¶¼ºÇÏ¿© ÀçȰÀ» ¸Å·ÂÀûÀ̰í È¿°úÀûÀ¸·Î ¸¸µì´Ï´Ù.

½Å°æÀçȰ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ù°, ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ³úÁ¹Áß ¹× ºÎ»ó »ç·Ê Áõ°¡°¡ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. µÑ°, ½Å°æ°úÇаú ÀçȰ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ È¿°ú¿Í äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼Â°, Á¶±â ¹× ÁýÁßÀûÀÎ ÀçȰÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½Å°æÀçȰ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Çコ ±â¼ú°ú ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ÅëÇÕÀº ÀçȰÀ» ´õ¿í Ä£¼÷ÇÏ°í °³º°È­ µÈ °ÍÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎÀÇ Áö¿ø Á¤Ã¥°ú ½Å°æ ÀçȰ ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀº ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í Àü¹® ÀçȰ¼¾ÅÍÀÇ °¡¿ë¼º Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(½Å°æ ·Îº¿ ½Ã½ºÅÛ, ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º, ¿þ¾î·¯ºí µð¹ÙÀ̽º, ³úÀÚ±Ø ±â±â), ¿ëµµ(³úÁ¹Áß, ÆÄŲ½¼º´, ³ú ¹× ô¼ö ¼Õ»ó, ³ú¼º¸¶ºñ, ´Ù¹ß¼º °æÈ­Áõ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 105°³»ç)

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è µµ¸ÞÀÎ Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

LSH 25.07.08

Global Neurorehabilitation Devices Market to Reach US$4.5 Billion by 2030

The global market for Neurorehabilitation Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Neurorobotic Systems, one of the segments analyzed in the report, is expected to record a 18.7% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Brain Computer Interface segment is estimated at 12.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$652.8 Million While China is Forecast to Grow at 21.1% CAGR

The Neurorehabilitation Devices market in the U.S. is estimated at US$652.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.2 Million by the year 2030 trailing a CAGR of 21.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

Global Neurorehabilitation Devices Market - Key Trends & Drivers Summarized

Neurorehabilitation devices are specialized tools designed to aid in the recovery and rehabilitation of individuals with neurological disorders and injuries. These devices are used to improve motor function, cognitive abilities, and overall quality of life for patients suffering from conditions such as stroke, spinal cord injuries, traumatic brain injuries, and neurodegenerative diseases like Parkinson’s and multiple sclerosis. Neurorehabilitation devices include robotic exoskeletons, brain-computer interfaces (BCIs), neurostimulation devices, and virtual reality (VR)-based rehabilitation systems. These technologies provide targeted therapy, facilitate repetitive training, and offer real-time feedback to enhance rehabilitation outcomes.

The development and implementation of neurorehabilitation devices are driven by advancements in neuroscience, robotics, and digital health technologies. Robotic exoskeletons and assistive devices enable patients to perform repetitive movements, promoting neuroplasticity and motor recovery. BCIs facilitate communication between the brain and external devices, helping patients regain control over their movements. Neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), modulate neural activity to improve cognitive and motor functions. VR-based systems create immersive environments for cognitive and physical exercises, making rehabilitation engaging and effective.

The growth in the neurorehabilitation devices market is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the rising number of stroke and injury cases are significant drivers. Secondly, advancements in neuroscience and rehabilitation technologies are enhancing the effectiveness and adoption of these devices. Thirdly, the growing awareness of the benefits of early and intensive rehabilitation is boosting demand for neurorehabilitation devices. Additionally, the integration of digital health technologies and remote monitoring is making rehabilitation more accessible and personalized. Furthermore, supportive government policies and funding for research and development in neurorehabilitation are encouraging innovation. Lastly, the expansion of healthcare infrastructure and the increasing availability of specialized rehabilitation centers are further driving market growth.

SCOPE OF STUDY:

The report analyzes the Neurorehabilitation Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Neurorobotic Systems, Brain Computer Interface, Wearable Devices, Brain Stimulators); Application (Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 105 Featured) -

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Neurological Disorders and Disability - A Prelude
    • Role of Neurorehabilitation in Enhancing Life Quality and Physical Function
    • An Insight into Neurorehabilitation Devices
    • Tariff Impact on Global Supply Chain Patterns
    • Competitive Landscape
    • Neurorehabilitation Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Market Prospects and Outlook
    • Global Neurorehabilitation Devices Market Radiates Signs of Vim & Vigor
    • Neurorehabilitation Remains Dynamic Domain with Progressive Advancements
    • Neuro-Robotic Devices: Thriving Segment of Neurorehabilitation Devices Market
    • Opportunity: Rising Uptake of Robotic Devices
    • Stroke Leads the End-uses of Neurorehabilitation Devices
    • North America Claims Authoritative Stake in Neurorehabilitation Devices Market
    • Immense Burden of Neurological Conditions in US Paves Way for Neurorehabilitation Devices
    • Asia-Pacific to Offer Lucrative Opportunities
    • Technological Advancements Drive Market Growth
    • Neurorehabilitation Becomes a Hotbed for VR & Robotic Technologies
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Market Restraints
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neurological Conditions Drive Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Adoption of Neurorobotic Systems
    • Exoskeleton Robots Add Sophistication in Neurorehabilitation
    • The Imminent Rise of Exosuits
    • Innovative Exosuits Wearable Robots Promise Accelerated Recovery of Stroke Patients
    • Robotic Exoskeletons as Game-Changing Development for Neurorehabilitation
    • AI Augments Prosthetic Technology
    • Researchers Develop Neurorobotic Prosthetic Arm to Restore Natural Brain Behaviors
    • Select Robotic Devices
    • Robot-assisted Therapy Vs Other Therapies
    • Limitations
    • Technological Developments
    • New Generation Robotic Neurorehabilitation Devices Powered by Non-invasive Brain Machine Interfaces
    • Brain Stimulators Seek to Widen their Role in Neurorehabilitation
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • Innovative Multi-Electrodes with Potential to Improve Spinal Cord Stimulation
    • Non-Invasive Brain Stimulation
    • Innovative Multi-electrode Stimulation Paves Way for Recovery from Spinal Cord Injuries
    • Neurorehabilitation Therapy in Epilepsy Care
    • Neurorehabilitation Wearable Devices Market Set to Deliver Stunning Performance
    • Novel Wristbands: A Primary Market Driver
    • Wearable Robotic Devices for Neurorehabilitation
    • Wearable Devices Set to Transform Traditional Approaches to Neurorehabilitation of Stroke Patients
    • Primary Wearable Sensors for Stroke Patients
    • Robotic Neurorehabilitation & Noninvasive Brain-Machine Interface to Aid Rehabilitation
    • Brain-Machine Interfaces
    • Key Applications of Virtual Reality for Neurological Rehabilitation
    • VR-Centric Gamification in Neurorehabilitation Improves Outcomes for Stroke Patients
    • Start-ups Leveraging VR for Gamification in Stroke Patient Rehabilitation
    • Technological Advancements in Neuroimaging Techniques Enhance Neurorehabilitation Outcome
    • Advancements in Robotics and Neuroscience Research Give Rise to Next-Generation Rehabilitation Techniques
    • IoT-Powered Rehabilitation Robotics
    • Integration Of Speech Recognition Algorithms
    • Emergence of Novel Multi-electrode Stimulation for Treatment of Spinal Cord Injuries
    • Startups Eye on Affordable Solutions to Spur Neurorehabilitation Uptake across Low- & Middle-Income Nations
    • Tailored and Affordable Neurorehab Technologies
    • Smartphone Technology to Support Neurorehabilitation
    • AR's role in Neurorehabilitation Recovery and Assessment
    • AR Augments the Existing Neurorehabilitation Programs
    • Electrotherapy Emerges a Mega Trend in Neuromuscular Rehabilitation Space
    • Why Metaverse Technology is Soaking Limelight for Holistic Neurological Rehabilitation
    • Neurological Disorders that Could Benefit from Metaverse
    • Moving from Mono-Therapeutic to Holistic Neurorehabilitation with Metaverse
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurorehabilitation Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurorehabilitation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurorobotic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurorobotic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurorobotic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Brain Computer Interface by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Brain Computer Interface by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Brain Computer Interface by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Wearable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Brain & Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Brain & Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Brain & Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cerebral Palsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cerebral Palsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cerebral Palsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Neurorehabilitation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neurorehabilitation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Neurorehabilitation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Neurorehabilitation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦